MobileSmith | September 15, 2022
MobileSmith a leading provider of cutting-edge mobile software solutions, announces delivery and live status of their PeriOp solution at CHI St. Vincent Infirmary.
MobileSmith Health is proud to partner with CHI St. Vincent in improving throughput and clinical care for surgical patients using the PeriOp solution. This toolset provides visibility of patient activities and status to the clinical team preparing to welcome patients for surgery. The adherence dashboard helps clinicians focus on the patients who need the most help. Patients, in turn, get education about their procedure, complete necessary preoperative tasks, and are better prepared to manage their care at home.
"We are thrilled to partner with CHI St. Vincent and their innovative team. Our work addresses patient outcomes while improving patient satisfaction. It also reduces the workload of clinical staff by automating routine tasks and improving predictability in patient throughput,"
Chris Caramanico, Chief Executive Officer of MobileSmith Health
"The MobileSmith Health team has been a pleasure to work with. We have a shared vision and passion to make healthcare communication to the patient reliable and more efficient. The combination of MobileSmith Health and our talented and innovative team at CHI St. Vincent are proving that we can make a difference in the daily work of many clinicians while improving patient outcomes," said Dr. Jill Flaxman, Medical Director of Perioperative Services.
MobileSmith Health is a digital health technology company focused on increasing efficiency and improving outcomes by providing clinicians with modern pre- and post-surgery dashboard, showing how patients participate in their own care. PeriOp, MobileSmith Health’s patient app, connects providers to their patients, streamlines information, simplifies surgery preparation and discharge and reduces complications. PeriOp by MobileSmith Health makes the science, process and oversight simple.
Allina Health and Flare Capital Partners | October 19, 2022
Allina Health and Flare Capital Partners announced the launch of Inbound Health, a new company that enables health systems and health plans to offer hospital-at-home and skilled nursing-at-home programs. These innovative new care models create the ability to care for patients requiring facility-level acute or post-acute care in their home, thereby improving patient access, satisfaction, and outcomes while lowering total cost of care.
Inbound Health provides the full stack of capabilities that are required to scale at-home care models including home-based care pathways, virtual care teams, engagement and workflow technology, analytics, supply chain partnerships, operational oversight and payment models. The company's flexible partnership structure enables customers to leverage their existing assets and capabilities while relying on Inbound Health to fill the gaps required to scale these programs across their service area
To date, more than 4,200 patients across 185 primary diagnoses have been cared for through the Inbound Health platform, which has been operational in Allina Health’s service area since May 2020. The program has allowed Allina Health to manage a wider swath of the continuum of care for its patients, thereby ensuring that care is delivered in a safe, coordinated and patient-centric manner. The company combines biometric monitoring, digital surveillance, in-home nursing and therapy, virtual visits with hospitalists and geriatricians, and a comprehensive supply chain to deliver a safe and high-quality care program.
Inbound Health has proven that the program lowers total-cost-of-care by 30-40% on a risk-adjusted basis while achieving similar or improved clinical outcomes when compared to traditional facility-based care. These outcomes have enabled Inbound Health and Allina to develop unique episodic-based payer contracts with multiple Commercial and Medicare Advantage payers in Minnesota, a payment model that the company plans on replicating with partners in other markets.
“The home hospital programs that we’ve scaled to thousands of patients here in Minnesota are rooted in our Population Health drivers of delivering safe, high quality, affordable care that’s timely and convenient to access. We are excited for Inbound Health to leverage the capabilities and know-how that power these programs to scale similar at-home programs across the nation.”
Lisa Shannon, President and CEO of Allina Health
Inbound Health will be led by CEO Dave Kerwar who brings a 20-year track record of executing leading-edge strategies to improve care quality, reduce cost, and create consumer-centricity in healthcare. Previously, Dave was the Chief Product Officer at Mount Sinai Health System where he built innovative technology-enabled operations to scale direct-to-consumer, direct-to-employer, and population health programs. Prior to Mount Sinai, Dave led business development for Aetna’s Joint Ventures where he launched Provider Owned Health Plans with leading health systems across the country.
“We are proud to be backed by one of the most prestigious health systems and one of the largest dedicated healthcare technology venture capital firms in the country in our pursuit to revolutionize this new level of care,” said Dave Kerwar. “Inbound Health will leverage the clinical, operational, and technology assets that we’ve developed alongside Allina Health to enable our customers nationwide to safely offer facility-level care in the home, at a lower cost and with an elevated patient and caregiver experience.”
Inbound Health will use the new financing to continue to advance its proprietary technology platform that integrates with a variety of biometric monitoring devices and brings forward engagement, workflow, and AI-powered analytic capabilities that are purpose-built to scale these at-home care programs. This platform optimizes Inbound Health’s ability to perform key functions on behalf of its partners, including:
“Home-based acute care models represent a compelling opportunity to lower the cost of care while increasing access and satisfaction for patients,” said Michael Greeley, Co-founder and General Partner, Flare Capital Partners. “Inbound Health is truly differentiated, not only due to the unique clinical and technology assets that underpin the platform, but also because it has powered one of the largest hospitals and SNF-at-home programs in the country. We look forward to partnering with Dave and the Inbound Health team to scale this platform nationally.”
About Allina Health
Allina Health is dedicated to the prevention and treatment of illness and enhancing the greater health of individuals, families and communities throughout Minnesota and western Wisconsin. A not-for-profit health care system, Allina Health cares for patients from beginning to end-of-life through its 90+ clinics, 12 hospitals, 14 retail pharmacies, specialty care centers and specialty medical services that provide home care, senior transitions, hospice care, home oxygen and medical equipment, and emergency medical transportation services.
About Flare Capital Partners
Flare Capital Partners strives to help build significant healthcare technology, digital health, and healthcare services companies to improve health outcomes and broaden access while lowering costs of care. We partner with inspirational entrepreneurs who seek to transform the business of healthcare by developing innovative and impactful products and services. Flare Capital is a team of proven healthcare technology investors and senior operating executives known for thought leadership and unparalleled strategic industry resources. Our firm has raised some of the industry’s largest dedicated venture capital funds focused on early-stage opportunities in healthcare technology innovation, and our investors include leading healthcare companies, major institutional investors, important family offices, foundations, and sovereign wealth funds. We are full life-cycle investors in our portfolio companies as we work alongside entrepreneurs over their entire company-building journey. Select portfolio companies include Aetion, Aspen RxHealth, Bright Heath, Cayaba Care, Cohere Health, Eden Health, HealthVerity, Inbound Health, Iora Health, Oshi Health, Somatus, and VisitPay. The firm has developed the very successful Flare Scholar program with over 250 participants and actively leverages its extended industry network, Executive Partners, and Industry Advisory Board for the benefit of the entrepreneurs and founders with whom it is privileged to partner.
Radius XR | October 03, 2022
IrisVision co-founder and CEO Ammad Khan today introduced a new company, Radius XR, to coincide with the opening of the American Academy of Ophthalmology 2022 meeting in Chicago. Radius XR builds on the therapeutic legacy of IrisVision by introducing diagnostic capability to the proprietary VR/AR assistive device.
After the CES Award-winning 2017 launch of IrisVision, which has helped thousands of legally blind individuals see again, the company sought to leverage its core technology to benefit the eyecare industry by creating a patient-guided exam process that makes it easier and more affordable to diagnose a range of vision problems that are pervasive in the U.S. More than 32 million Americans aged 18+ are affected by vision loss, according to the IPUMS National Health Interview Survey1.
Using a single Radius XR headset, patients can self-perform a range of vision tests that are clinically equivalent to gold standard exams. The exams currently performed with the Radius XR testing platform are Visual Field, Visual Acuity, Contrast Sensitivity, Amsler Grid, and Color Scheme. Development is ongoing.
The shift to patient-guided testing enhances eyecare practice workflow and enables a single technician to administer several test sessions concurrently, doubling patient capacity.
The fashion-forward design of Radius XR is a significant leap forward in wearable devices, with the look and feel of a pair of fashionable sunglasses. Radius XR is the industry’s lightest wearable device, weighing just under 6 oz., and features all-day battery life.
The small, lightweight design overcomes the challenges of expensive and bulky legacy devices that force patients to sit in uncomfortable positions for testing. Exams can be conducted beyond exam lanes, allowing a patient’s exam in nontraditional spaces like waiting rooms, remote offices, and lobbies. With Radius XR, opportunities for greater accessibility and care are boundless.
A breakthrough feature of the Radius XR platform is the immersive educational media library that can be tailored to each patient. This content is configured by each practice to display at an appropriate time during the exam experience automatically, eliminating the repetitive, time-consuming task of providing patients with educational information about their vision challenges while ensuring relevant information is consistently presented.
The platform includes a Business Suite of management tools that streamline patient check-in, enable staff to customize the experience for multiple patients, and make it easier for eyecare professionals to manage business aspects critical to their practice's ongoing success.
Trefethen named Radius XR CMO
The launch of Radius XR is guided by John Trefethen, who joins the company as Chief Marketing Officer. Trefethen previously served in leadership roles at several medical device companies, including industry giants Zeiss Medical Technology and Topcon Healthcare.
“Early diagnosis is the key to treating many conditions that can lead to vision loss. We believe a testing platform that combines a comfortable size with an engaging, immersive experience makes patients more likely to seek testing — and to be re-tested more frequently. Diagnosing conditions earlier and regularly tracking disease progression gives eyecare professionals an immense advantage in caring for their patients’ vision.
About Radius XR – RadiusXR
The Radius XR platform is a portable vision diagnostic and patient engagement system that combines medical-grade diagnostics, business management, and patient education tools in a single wearable AR/VR device.
The RadiusExam® proprietary algorithm provides diagnostic testing results equivalent to current exam gold standards, with the clinical science validated by Deming regression. As the algorithm presents stimuli to patients, Radius Adaptive® responds to maximize the algorithm's speed.
The total hardware and software system helps medical professionals diagnose patients with accuracy, grow their eyecare practices, enhance patient engagement, and reduce staff workload by enabling patients to perform self-guided vision exams with minimal supervision.
Radius XR builds on the therapeutic legacy of IrisVision, the first clinically validated wearable low vision solution. IrisVision was backed by a research grant from the National Eye Institute and developed in collaboration with researchers from top ophthalmology centers at Johns Hopkins University, Stanford University, and UPMC Pittsburg.